3c-p

From DMT-Nexus Wiki
Revision as of 08:43, 12 June 2013 by TheTraveler (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Safety profile
Category:
Main effects:
Side effects:
Health risks:
Important safety remarks:



Brief overview - What is 3C-P

3C-P is a psychedelic phenethylamine. It has structural and pharmacodynamic properties similar to the drugs mescaline, proscaline, and amphetamine. Little information exists on the human pharmacology of 3C-P, but a psychedelic dosage appears to be 20-40mg, and is accompanied by stimulant effects.

Chemically 3C-P is 4-propoxy-3,5-dimethoxyamphetamine, with the formula C14H23NO3. Although its name is similar to the psychedelic phenethylamine 2C-P, it is much closer in structure to mescaline, and proscaline. 3C-P is the 3-carbon homologue of proscaline.

3C-P is mentioned briefly in PiHKAL as the unexplored "amphetamine homologue" of proscaline (#140, or "P"). Very little is known about this substance and it should not be considered safe for human ingestion.

Type

Stimulant, possible psychedelic or empathogen.

Dosage

Very rough estimates. Threshold 5-10 mg; Medium 10-40 mg; Strong 40+ mg.

Duration

Probably long, 8 - 16 hours.

Safety

Unknown.

Field Tests

Marquis reagent reacts orange with the 3C-P sold in 2003.

Experiences

We know of a dozen or so reports of human 3C-P ingestion. Various authors, unverified provenance: 8 mg: "I want to call this a threshold"; 16 mg: "something like 5 mg of Adderall"; 20 mg: "overall, the experience was very mild"; 30 mg: "+3 euphoric period lasting 3 hours-ish and then a +2 psychedelic amphetamine feeling for another 12+ hours... unable to sleep (and kind of tired) is pretty annoying"; 30 mg: "for me, 30 mg was perfect... [but] I should reiterate that the duration was annoying"; 40 mg: "an average dose".

Literature Mentions

  • Shulgin A, Shulgin A. PiHKAL: A Chemical Love Story. Transform Press, 1991.
  • Trachsel D. "Synthesis of novel (phenylalkyl)amines for the investigation of structure-activity relationships: part 1 mescaline derivatives", helvetica Chimica Acta. 2003; 85(9):3019-26.